The global Oligonucleotide Synthesis market is projected to grow from US$ 2030.5 million in 2023 to US$ 2946.1 million by 2029, at a Compound Annual Growth Rate (CAGR) of 6.4% during the forecast period.

Oligonucleotide Synthesis Market

Oligonucleotide synthesis is the chemical synthesis of relatively short fragments of nucleic acids with defined chemical structure (sequence). The technique is extremely useful in current laboratory practice because it provides a rapid and inexpensive access to custom-made oligonucleotides of the desired sequence.

Market Analysis and Insights: Global Oligonucleotide Synthesis Market

Oligonucleotides find a variety of applications in molecular biology and medicine. They are most commonly used as antisense oligonucleotides, small interfering RNA, primers for DNA sequencing and amplification, probes for detecting complementary DNA or RNA via molecular hybridization, tools for the targeted introduction of mutations and restriction sites, and for the synthesis of artificial genes.

Report Includes

This report presents an overview of global market for Oligonucleotide Synthesis market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Oligonucleotide Synthesis, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Oligonucleotide Synthesis, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Oligonucleotide Synthesis revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Oligonucleotide Synthesis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by end user, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Oligonucleotide Synthesis revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Integrated DNA Technologies, Merck, Eurofins Genomics, Thermo Fisher Scientific, Agilent Technologies, Eurogentec, GE Healthcare, LGC Biosearch Technologies and Nitto Denko Avecia, etc.

Scope of Oligonucleotide Synthesis Market Report

Report Metric	Details
Report Name	Oligonucleotide Synthesis Market
Accounted market size in 2023	US$ 2030.5 million
Forecasted market size in 2029	US$ 2946.1 million
CAGR	6.4
Base Year	2023
Forecasted years	2023 - 2029
Segment by Type	Custom Oligonucleotides Pre-designed Oligonucleotides
Segment by End User	Academic Research Institutes Pharmaceutical and Biotechnology Companies Diagnostic Laboratories Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Integrated DNA Technologies, Merck, Eurofins Genomics, Thermo Fisher Scientific, Agilent Technologies, Eurogentec, GE Healthcare, LGC Biosearch Technologies, Nitto Denko Avecia, Genscript, Genedesign, TriLink Biotechnologies, Bio-Synthesis, ATDBio
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Oligonucleotide Synthesis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oligonucleotide Synthesis companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by end user, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by end user and by country, revenue for each segment.
Chapter 7: Europe by type, by end user and by country, revenue for each segment.
Chapter 8: China by type and by end user revenue for each segment.
Chapter 9: Asia (excluding China) by type, by end user and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by end user and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oligonucleotide Synthesis revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Oligonucleotide Synthesis Market growing?

Ans: The Oligonucleotide Synthesis Market witnessing a CAGR of 6.4 during the forecast period 2023-2029.

What is the Oligonucleotide Synthesis Market size in 2029?

Ans: The global Oligonucleotide Synthesis market is projected to grow from US$ 2030.5 million in 2023 to US$ 2946.1 million by 2029, at a Compound Annual Growth Rate (CAGR) of 6.4% during the forecast period.

Who are the main players in the Oligonucleotide Synthesis Market report?

Ans: The main players in the Oligonucleotide Synthesis Market are Integrated DNA Technologies, Merck, Eurofins Genomics, Thermo Fisher Scientific, Agilent Technologies, Eurogentec, GE Healthcare, LGC Biosearch Technologies, Nitto Denko Avecia, Genscript, Genedesign, TriLink Biotechnologies, Bio-Synthesis, ATDBio

What are the Type segmentation covered in the Oligonucleotide Synthesis Market report?

Ans: The Types covered in the Oligonucleotide Synthesis Market report are Custom Oligonucleotides, Pre-designed Oligonucleotides

What are the End User segmentation covered in the Oligonucleotide Synthesis Market report?

Ans: The End users covered in the Oligonucleotide Synthesis Market report are Academic Research Institutes, Pharmaceutical and Biotechnology Companies, Diagnostic Laboratories, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Oligonucleotide Synthesis Market Size Growth Rate by Type, 2018 VS 2022 VS 2029

1.2.2 Custom Oligonucleotides

1.2.3 Pre-designed Oligonucleotides

1.3 Market by End User

1.3.1 Global Oligonucleotide Synthesis Market Size Growth Rate by End User, 2018 VS 2022 VS 2029

1.3.2 Academic Research Institutes

1.3.3 Pharmaceutical and Biotechnology Companies

1.3.4 Diagnostic Laboratories

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Oligonucleotide Synthesis Market Perspective (2018-2029)

2.2 Global Oligonucleotide Synthesis Growth Trends by Region

2.2.1 Oligonucleotide Synthesis Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Oligonucleotide Synthesis Historic Market Size by Region (2018-2023)

2.2.3 Oligonucleotide Synthesis Forecasted Market Size by Region (2024-2029)

2.3 Oligonucleotide Synthesis Market Dynamics

2.3.1 Oligonucleotide Synthesis Industry Trends

2.3.2 Oligonucleotide Synthesis Market Drivers

2.3.3 Oligonucleotide Synthesis Market Challenges

2.3.4 Oligonucleotide Synthesis Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Oligonucleotide Synthesis by Players

3.1.1 Global Oligonucleotide Synthesis Revenue by Players (2018-2023)

3.1.2 Global Oligonucleotide Synthesis Revenue Market Share by Players (2018-2023)

3.2 Global Oligonucleotide Synthesis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Oligonucleotide Synthesis, Ranking by Revenue, 2021 VS 2022 VS 2023

3.4 Global Oligonucleotide Synthesis Market Concentration Ratio

3.4.1 Global Oligonucleotide Synthesis Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Oligonucleotide Synthesis Revenue in 2022

3.5 Global Key Players of Oligonucleotide Synthesis Head office and Area Served

3.6 Global Key Players of Oligonucleotide Synthesis, Product and Application

3.7 Global Key Players of Oligonucleotide Synthesis, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Oligonucleotide Synthesis Breakdown Data by Type

4.1 Global Oligonucleotide Synthesis Historic Market Size by Type (2018-2023)

4.2 Global Oligonucleotide Synthesis Forecasted Market Size by Type (2024-2029)

5 Oligonucleotide Synthesis Breakdown Data by End User

5.1 Global Oligonucleotide Synthesis Historic Market Size by End User (2018-2023)

5.2 Global Oligonucleotide Synthesis Forecasted Market Size by End User (2024-2029)

6 North America

6.1 North America Oligonucleotide Synthesis Market Size (2018-2029)

6.2 North America Oligonucleotide Synthesis Market Size by Type

6.2.1 North America Oligonucleotide Synthesis Market Size by Type (2018-2023)

6.2.2 North America Oligonucleotide Synthesis Market Size by Type (2024-2029)

6.2.3 North America Oligonucleotide Synthesis Market Share by Type (2018-2029)

6.3 North America Oligonucleotide Synthesis Market Size by End User

6.3.1 North America Oligonucleotide Synthesis Market Size by End User (2018-2023)

6.3.2 North America Oligonucleotide Synthesis Market Size by End User (2024-2029)

6.3.3 North America Oligonucleotide Synthesis Market Share by End User (2018-2029)

6.4 North America Oligonucleotide Synthesis Market Size by Country

6.4.1 North America Oligonucleotide Synthesis Market Size by Country: 2018 VS 2022 VS 2029

6.4.2 North America Oligonucleotide Synthesis Market Size by Country (2018-2023)

6.4.3 North America Oligonucleotide Synthesis Market Size by Country (2024-2029)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Oligonucleotide Synthesis Market Size (2018-2029)

7.2 Europe Oligonucleotide Synthesis Market Size by Type

7.2.1 Europe Oligonucleotide Synthesis Market Size by Type (2018-2023)

7.2.2 Europe Oligonucleotide Synthesis Market Size by Type (2024-2029)

7.2.3 Europe Oligonucleotide Synthesis Market Share by Type (2018-2029)

7.3 Europe Oligonucleotide Synthesis Market Size by End User

7.3.1 Europe Oligonucleotide Synthesis Market Size by End User (2018-2023)

7.3.2 Europe Oligonucleotide Synthesis Market Size by End User (2024-2029)

7.3.3 Europe Oligonucleotide Synthesis Market Share by End User (2018-2029)

7.4 Europe Oligonucleotide Synthesis Market Size by Country

7.4.1 Europe Oligonucleotide Synthesis Market Size by Country: 2018 VS 2022 VS 2029

7.4.2 Europe Oligonucleotide Synthesis Market Size by Country (2018-2023)

7.4.3 Europe Oligonucleotide Synthesis Market Size by Country (2024-2029)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Oligonucleotide Synthesis Market Size (2018-2029)

8.2 China Oligonucleotide Synthesis Market Size by Type

8.2.1 China Oligonucleotide Synthesis Market Size by Type (2018-2023)

8.2.2 China Oligonucleotide Synthesis Market Size by Type (2024-2029)

8.2.3 China Oligonucleotide Synthesis Market Share by Type (2018-2029)

8.3 China Oligonucleotide Synthesis Market Size by End User

8.3.1 China Oligonucleotide Synthesis Market Size by End User (2018-2023)

8.3.2 China Oligonucleotide Synthesis Market Size by End User (2024-2029)

8.3.3 China Oligonucleotide Synthesis Market Share by End User (2018-2029)

9 Asia (excluding China)

9.1 Asia Oligonucleotide Synthesis Market Size (2018-2029)

9.2 Asia Oligonucleotide Synthesis Market Size by Type

9.2.1 Asia Oligonucleotide Synthesis Market Size by Type (2018-2023)

9.2.2 Asia Oligonucleotide Synthesis Market Size by Type (2024-2029)

9.2.3 Asia Oligonucleotide Synthesis Market Share by Type (2018-2029)

9.3 Asia Oligonucleotide Synthesis Market Size by End User

9.3.1 Asia Oligonucleotide Synthesis Market Size by End User (2018-2023)

9.3.2 Asia Oligonucleotide Synthesis Market Size by End User (2024-2029)

9.3.3 Asia Oligonucleotide Synthesis Market Share by End User (2018-2029)

9.4 Asia Oligonucleotide Synthesis Market Size by Region

9.4.1 Asia Oligonucleotide Synthesis Market Size by Region: 2018 VS 2022 VS 2029

9.4.2 Asia Oligonucleotide Synthesis Market Size by Region (2018-2023)

9.4.3 Asia Oligonucleotide Synthesis Market Size by Region (2024-2029)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Oligonucleotide Synthesis Market Size (2018-2029)

10.2 Middle East, Africa, and Latin America Oligonucleotide Synthesis Market Size by Type

10.2.1 Middle East, Africa, and Latin America Oligonucleotide Synthesis Market Size by Type (2018-2023)

10.2.2 Middle East, Africa, and Latin America Oligonucleotide Synthesis Market Size by Type (2024-2029)

10.2.3 Middle East, Africa, and Latin America Oligonucleotide Synthesis Market Share by Type (2018-2029)

10.3 Middle East, Africa, and Latin America Oligonucleotide Synthesis Market Size by End User

10.3.1 Middle East, Africa, and Latin America Oligonucleotide Synthesis Market Size by End User (2018-2023)

10.3.2 Middle East, Africa, and Latin America Oligonucleotide Synthesis Market Size by End User (2024-2029)

10.3.3 Middle East, Africa, and Latin America Oligonucleotide Synthesis Market Share by End User (2018-2029)

10.4 Middle East, Africa, and Latin America Oligonucleotide Synthesis Market Size by Country

10.4.1 Middle East, Africa, and Latin America Oligonucleotide Synthesis Market Size by Country: 2018 VS 2022 VS 2029

10.4.2 Middle East, Africa, and Latin America Oligonucleotide Synthesis Market Size by Country (2018-2023)

10.4.3 Middle East, Africa, and Latin America Oligonucleotide Synthesis Market Size by Country (2024-2029)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Integrated DNA Technologies

11.1.1 Integrated DNA Technologies Company Details

11.1.2 Integrated DNA Technologies Business Overview

11.1.3 Integrated DNA Technologies Oligonucleotide Synthesis Introduction

11.1.4 Integrated DNA Technologies Revenue in Oligonucleotide Synthesis Business (2018-2023)

11.1.5 Integrated DNA Technologies Recent Developments

11.2 Merck

11.2.1 Merck Company Details

11.2.2 Merck Business Overview

11.2.3 Merck Oligonucleotide Synthesis Introduction

11.2.4 Merck Revenue in Oligonucleotide Synthesis Business (2018-2023)

11.2.5 Merck Recent Developments

11.3 Eurofins Genomics

11.3.1 Eurofins Genomics Company Details

11.3.2 Eurofins Genomics Business Overview

11.3.3 Eurofins Genomics Oligonucleotide Synthesis Introduction

11.3.4 Eurofins Genomics Revenue in Oligonucleotide Synthesis Business (2018-2023)

11.3.5 Eurofins Genomics Recent Developments

11.4 Thermo Fisher Scientific

11.4.1 Thermo Fisher Scientific Company Details

11.4.2 Thermo Fisher Scientific Business Overview

11.4.3 Thermo Fisher Scientific Oligonucleotide Synthesis Introduction

11.4.4 Thermo Fisher Scientific Revenue in Oligonucleotide Synthesis Business (2018-2023)

11.4.5 Thermo Fisher Scientific Recent Developments

11.5 Agilent Technologies

11.5.1 Agilent Technologies Company Details

11.5.2 Agilent Technologies Business Overview

11.5.3 Agilent Technologies Oligonucleotide Synthesis Introduction

11.5.4 Agilent Technologies Revenue in Oligonucleotide Synthesis Business (2018-2023)

11.5.5 Agilent Technologies Recent Developments

11.6 Eurogentec

11.6.1 Eurogentec Company Details

11.6.2 Eurogentec Business Overview

11.6.3 Eurogentec Oligonucleotide Synthesis Introduction

11.6.4 Eurogentec Revenue in Oligonucleotide Synthesis Business (2018-2023)

11.6.5 Eurogentec Recent Developments

11.7 GE Healthcare

11.7.1 GE Healthcare Company Details

11.7.2 GE Healthcare Business Overview

11.7.3 GE Healthcare Oligonucleotide Synthesis Introduction

11.7.4 GE Healthcare Revenue in Oligonucleotide Synthesis Business (2018-2023)

11.7.5 GE Healthcare Recent Developments

11.8 LGC Biosearch Technologies

11.8.1 LGC Biosearch Technologies Company Details

11.8.2 LGC Biosearch Technologies Business Overview

11.8.3 LGC Biosearch Technologies Oligonucleotide Synthesis Introduction

11.8.4 LGC Biosearch Technologies Revenue in Oligonucleotide Synthesis Business (2018-2023)

11.8.5 LGC Biosearch Technologies Recent Developments

11.9 Nitto Denko Avecia

11.9.1 Nitto Denko Avecia Company Details

11.9.2 Nitto Denko Avecia Business Overview

11.9.3 Nitto Denko Avecia Oligonucleotide Synthesis Introduction

11.9.4 Nitto Denko Avecia Revenue in Oligonucleotide Synthesis Business (2018-2023)

11.9.5 Nitto Denko Avecia Recent Developments

11.10 Genscript

11.10.1 Genscript Company Details

11.10.2 Genscript Business Overview

11.10.3 Genscript Oligonucleotide Synthesis Introduction

11.10.4 Genscript Revenue in Oligonucleotide Synthesis Business (2018-2023)

11.10.5 Genscript Recent Developments

11.11 Genedesign

11.11.1 Genedesign Company Details

11.11.2 Genedesign Business Overview

11.11.3 Genedesign Oligonucleotide Synthesis Introduction

11.11.4 Genedesign Revenue in Oligonucleotide Synthesis Business (2018-2023)

11.11.5 Genedesign Recent Developments

11.12 TriLink Biotechnologies

11.12.1 TriLink Biotechnologies Company Details

11.12.2 TriLink Biotechnologies Business Overview

11.12.3 TriLink Biotechnologies Oligonucleotide Synthesis Introduction

11.12.4 TriLink Biotechnologies Revenue in Oligonucleotide Synthesis Business (2018-2023)

11.12.5 TriLink Biotechnologies Recent Developments

11.13 Bio-Synthesis

11.13.1 Bio-Synthesis Company Details

11.13.2 Bio-Synthesis Business Overview

11.13.3 Bio-Synthesis Oligonucleotide Synthesis Introduction

11.13.4 Bio-Synthesis Revenue in Oligonucleotide Synthesis Business (2018-2023)

11.13.5 Bio-Synthesis Recent Developments

11.14 ATDBio

11.14.1 ATDBio Company Details

11.14.2 ATDBio Business Overview

11.14.3 ATDBio Oligonucleotide Synthesis Introduction

11.14.4 ATDBio Revenue in Oligonucleotide Synthesis Business (2018-2023)

11.14.5 ATDBio Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Integrated DNA Technologies

Merck

Eurofins Genomics

Thermo Fisher Scientific

Agilent Technologies

Eurogentec S.A

GE Healthcare

LGC Biosearch Technologies

Nitto Denko Avecia

GenScript

GeneDesign

TriLink BioTechnologies

Bio-Synthesis

ATDBio

List of Tables

Table 1. Global Oligonucleotide Synthesis Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029

Table 2. Key Players of Custom Oligonucleotides

Table 3. Key Players of Pre-designed Oligonucleotides

Table 4. Global Oligonucleotide Synthesis Market Size Growth Rate by End User (US$ Million), 2018 VS 2022 VS 2029

Table 5. Global Oligonucleotide Synthesis Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 6. Global Oligonucleotide Synthesis Market Size by Region (2018-2023) & (US$ Million)

Table 7. Global Oligonucleotide Synthesis Market Share by Region (2018-2023)

Table 8. Global Oligonucleotide Synthesis Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 9. Global Oligonucleotide Synthesis Market Share by Region (2024-2029)

Table 10. Oligonucleotide Synthesis Market Trends

Table 11. Oligonucleotide Synthesis Market Drivers

Table 12. Oligonucleotide Synthesis Market Challenges

Table 13. Oligonucleotide Synthesis Market Restraints

Table 14. Global Oligonucleotide Synthesis Revenue by Players (2018-2023) & (US$ Million)

Table 15. Global Oligonucleotide Synthesis Revenue Share by Players (2018-2023)

Table 16. Global Top Oligonucleotide Synthesis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotide Synthesis as of 2022)

Table 17. Global Oligonucleotide Synthesis Industry Ranking 2021 VS 2022 VS 2023

Table 18. Global 5 Largest Players Market Share by Oligonucleotide Synthesis Revenue (CR5 and HHI) & (2018-2023)

Table 19. Global Key Players of Oligonucleotide Synthesis, Headquarters and Area Served

Table 20. Global Key Players of Oligonucleotide Synthesis, Product and Application

Table 21. Global Key Players of Oligonucleotide Synthesis, Product and Application

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Oligonucleotide Synthesis Market Size by Type (2018-2023) & (US$ Million)

Table 24. Global Oligonucleotide Synthesis Revenue Market Share by Type (2018-2023)

Table 25. Global Oligonucleotide Synthesis Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 26. Global Oligonucleotide Synthesis Revenue Market Share by Type (2024-2029)

Table 27. Global Oligonucleotide Synthesis Market Size by End User (2018-2023) & (US$ Million)

Table 28. Global Oligonucleotide Synthesis Revenue Share by End User (2018-2023)

Table 29. Global Oligonucleotide Synthesis Forecasted Market Size by End User (2024-2029) & (US$ Million)

Table 30. Global Oligonucleotide Synthesis Revenue Share by End User (2024-2029)

Table 31. North America Oligonucleotide Synthesis Market Size by Type (2018-2023) & (US$ Million)

Table 32. North America Oligonucleotide Synthesis Market Size by Type (2024-2029) & (US$ Million)

Table 33. North America Oligonucleotide Synthesis Market Size by End User (2018-2023) & (US$ Million)

Table 34. North America Oligonucleotide Synthesis Market Size by End User (2024-2029) & (US$ Million)

Table 35. North America Oligonucleotide Synthesis Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 36. North America Oligonucleotide Synthesis Market Size by Country (2018-2023) & (US$ Million)

Table 37. North America Oligonucleotide Synthesis Market Size by Country (2024-2029) & (US$ Million)

Table 38. Europe Oligonucleotide Synthesis Market Size by Type (2018-2023) & (US$ Million)

Table 39. Europe Oligonucleotide Synthesis Market Size by Type (2024-2029) & (US$ Million)

Table 40. Europe Oligonucleotide Synthesis Market Size by End User (2018-2023) & (US$ Million)

Table 41. Europe Oligonucleotide Synthesis Market Size by End User (2024-2029) & (US$ Million)

Table 42. Europe Oligonucleotide Synthesis Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 43. Europe Oligonucleotide Synthesis Market Size by Country (2018-2023) & (US$ Million)

Table 44. Europe Oligonucleotide Synthesis Market Size by Country (2024-2029) & (US$ Million)

Table 45. China Oligonucleotide Synthesis Market Size by Type (2018-2023) & (US$ Million)

Table 46. China Oligonucleotide Synthesis Market Size by Type (2024-2029) & (US$ Million)

Table 47. China Oligonucleotide Synthesis Market Size by End User (2018-2023) & (US$ Million)

Table 48. China Oligonucleotide Synthesis Market Size by End User (2024-2029) & (US$ Million)

Table 49. Asia Oligonucleotide Synthesis Market Size by Type (2018-2023) & (US$ Million)

Table 50. Asia Oligonucleotide Synthesis Market Size by Type (2024-2029) & (US$ Million)

Table 51. Asia Oligonucleotide Synthesis Market Size by End User (2018-2023) & (US$ Million)

Table 52. Asia Oligonucleotide Synthesis Market Size by End User (2024-2029) & (US$ Million)

Table 53. Asia Oligonucleotide Synthesis Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 54. Asia Oligonucleotide Synthesis Market Size by Region (2018-2023) & (US$ Million)

Table 55. Asia Oligonucleotide Synthesis Market Size by Region (2024-2029) & (US$ Million)

Table 56. Middle East, Africa, and Latin America Oligonucleotide Synthesis Market Size by Type (2018-2023) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Oligonucleotide Synthesis Market Size by Type (2024-2029) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Oligonucleotide Synthesis Market Size by End User (2018-2023) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Oligonucleotide Synthesis Market Size by End User (2024-2029) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Oligonucleotide Synthesis Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 61. Middle East, Africa, and Latin America Oligonucleotide Synthesis Market Size by Country (2018-2023) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Oligonucleotide Synthesis Market Size by Country (2024-2029) & (US$ Million)

Table 63. Integrated DNA Technologies Company Details

Table 64. Integrated DNA Technologies Business Overview

Table 65. Integrated DNA Technologies Oligonucleotide Synthesis Product

Table 66. Integrated DNA Technologies Revenue in Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)

Table 67. Integrated DNA Technologies Recent Developments

Table 68. Merck Company Details

Table 69. Merck Business Overview

Table 70. Merck Oligonucleotide Synthesis Product

Table 71. Merck Revenue in Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)

Table 72. Merck Recent Developments

Table 73. Eurofins Genomics Company Details

Table 74. Eurofins Genomics Business Overview

Table 75. Eurofins Genomics Oligonucleotide Synthesis Product

Table 76. Eurofins Genomics Revenue in Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)

Table 77. Eurofins Genomics Recent Developments

Table 78. Thermo Fisher Scientific Company Details

Table 79. Thermo Fisher Scientific Business Overview

Table 80. Thermo Fisher Scientific Oligonucleotide Synthesis Product

Table 81. Thermo Fisher Scientific Revenue in Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)

Table 82. Thermo Fisher Scientific Recent Developments

Table 83. Agilent Technologies Company Details

Table 84. Agilent Technologies Business Overview

Table 85. Agilent Technologies Oligonucleotide Synthesis Product

Table 86. Agilent Technologies Revenue in Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)

Table 87. Agilent Technologies Recent Developments

Table 88. Eurogentec Company Details

Table 89. Eurogentec Business Overview

Table 90. Eurogentec Oligonucleotide Synthesis Product

Table 91. Eurogentec Revenue in Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)

Table 92. Eurogentec Recent Developments

Table 93. GE Healthcare Company Details

Table 94. GE Healthcare Business Overview

Table 95. GE Healthcare Oligonucleotide Synthesis Product

Table 96. GE Healthcare Revenue in Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)

Table 97. GE Healthcare Recent Developments

Table 98. LGC Biosearch Technologies Company Details

Table 99. LGC Biosearch Technologies Business Overview

Table 100. LGC Biosearch Technologies Oligonucleotide Synthesis Product

Table 101. LGC Biosearch Technologies Revenue in Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)

Table 102. LGC Biosearch Technologies Recent Developments

Table 103. Nitto Denko Avecia Company Details

Table 104. Nitto Denko Avecia Business Overview

Table 105. Nitto Denko Avecia Oligonucleotide Synthesis Product

Table 106. Nitto Denko Avecia Revenue in Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)

Table 107. Nitto Denko Avecia Recent Developments

Table 108. Genscript Company Details

Table 109. Genscript Business Overview

Table 110. Genscript Oligonucleotide Synthesis Product

Table 111. Genscript Revenue in Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)

Table 112. Genscript Recent Developments

Table 113. Genedesign Company Details

Table 114. Genedesign Business Overview

Table 115. Genedesign Oligonucleotide Synthesis Product

Table 116. Genedesign Revenue in Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)

Table 117. Genedesign Recent Developments

Table 118. TriLink Biotechnologies Company Details

Table 119. TriLink Biotechnologies Business Overview

Table 120. TriLink Biotechnologies Oligonucleotide Synthesis Product

Table 121. TriLink Biotechnologies Revenue in Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)

Table 122. TriLink Biotechnologies Recent Developments

Table 123. Bio-Synthesis Company Details

Table 124. Bio-Synthesis Business Overview

Table 125. Bio-Synthesis Oligonucleotide Synthesis Product

Table 126. Bio-Synthesis Revenue in Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)

Table 127. Bio-Synthesis Recent Developments

Table 128. ATDBio Company Details

Table 129. ATDBio Business Overview

Table 130. ATDBio Oligonucleotide Synthesis Product

Table 131. ATDBio Revenue in Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)

Table 132. ATDBio Recent Developments

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Oligonucleotide Synthesis Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

Figure 2. Global Oligonucleotide Synthesis Market Share by Type: 2022 VS 2029

Figure 3. Custom Oligonucleotides Features

Figure 4. Pre-designed Oligonucleotides Features

Figure 5. Global Oligonucleotide Synthesis Market Size Growth Rate by End User, 2018 VS 2022 VS 2029 (US$ Million)

Figure 6. Global Oligonucleotide Synthesis Market Share by End User: 2022 VS 2029

Figure 7. Academic Research Institutes Case Studies

Figure 8. Pharmaceutical and Biotechnology Companies Case Studies

Figure 9. Diagnostic Laboratories Case Studies

Figure 10. Others Case Studies

Figure 11. Oligonucleotide Synthesis Report Years Considered

Figure 12. Global Oligonucleotide Synthesis Market Size (US$ Million), Year-over-Year: 2018-2029

Figure 13. Global Oligonucleotide Synthesis Market Size, (US$ Million), 2018 VS 2022 VS 2029

Figure 14. Global Oligonucleotide Synthesis Market Share by Region: 2022 VS 2029

Figure 15. Global Oligonucleotide Synthesis Market Share by Players in 2022

Figure 16. Global Top Oligonucleotide Synthesis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotide Synthesis as of 2022)

Figure 17. The Top 10 and 5 Players Market Share by Oligonucleotide Synthesis Revenue in 2022

Figure 18. North America Oligonucleotide Synthesis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 19. North America Oligonucleotide Synthesis Market Share by Type (2018-2029)

Figure 20. North America Oligonucleotide Synthesis Market Share by End User (2018-2029)

Figure 21. North America Oligonucleotide Synthesis Market Share by Country (2018-2029)

Figure 22. United States Oligonucleotide Synthesis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 23. Canada Oligonucleotide Synthesis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 24. Europe Oligonucleotide Synthesis Market Size YoY (2018-2029) & (US$ Million)

Figure 25. Europe Oligonucleotide Synthesis Market Share by Type (2018-2029)

Figure 26. Europe Oligonucleotide Synthesis Market Share by End User (2018-2029)

Figure 27. Europe Oligonucleotide Synthesis Market Share by Country (2018-2029)

Figure 28. Germany Oligonucleotide Synthesis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 29. France Oligonucleotide Synthesis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 30. U.K. Oligonucleotide Synthesis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 31. Italy Oligonucleotide Synthesis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 32. Russia Oligonucleotide Synthesis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 33. Nordic Countries Oligonucleotide Synthesis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 34. China Oligonucleotide Synthesis Market Size YoY (2018-2029) & (US$ Million)

Figure 35. China Oligonucleotide Synthesis Market Share by Type (2018-2029)

Figure 36. China Oligonucleotide Synthesis Market Share by End User (2018-2029)

Figure 37. Asia Oligonucleotide Synthesis Market Size YoY (2018-2029) & (US$ Million)

Figure 38. Asia Oligonucleotide Synthesis Market Share by Type (2018-2029)

Figure 39. Asia Oligonucleotide Synthesis Market Share by End User (2018-2029)

Figure 40. Asia Oligonucleotide Synthesis Market Share by Region (2018-2029)

Figure 41. Japan Oligonucleotide Synthesis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 42. South Korea Oligonucleotide Synthesis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 43. China Taiwan Oligonucleotide Synthesis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 44. Southeast Asia Oligonucleotide Synthesis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 45. India Oligonucleotide Synthesis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 46. Australia Oligonucleotide Synthesis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Oligonucleotide Synthesis Market Size YoY (2018-2029) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Oligonucleotide Synthesis Market Share by Type (2018-2029)

Figure 49. Middle East, Africa, and Latin America Oligonucleotide Synthesis Market Share by End User (2018-2029)

Figure 50. Middle East, Africa, and Latin America Oligonucleotide Synthesis Market Share by Country (2018-2029)

Figure 51. Brazil Oligonucleotide Synthesis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 52. Mexico Oligonucleotide Synthesis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 53. Turkey Oligonucleotide Synthesis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 54. Saudi Arabia Oligonucleotide Synthesis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 55. Israel Oligonucleotide Synthesis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 56. GCC Countries Oligonucleotide Synthesis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 57. Integrated DNA Technologies Revenue Growth Rate in Oligonucleotide Synthesis Business (2018-2023)

Figure 58. Merck Revenue Growth Rate in Oligonucleotide Synthesis Business (2018-2023)

Figure 59. Eurofins Genomics Revenue Growth Rate in Oligonucleotide Synthesis Business (2018-2023)

Figure 60. Thermo Fisher Scientific Revenue Growth Rate in Oligonucleotide Synthesis Business (2018-2023)

Figure 61. Agilent Technologies Revenue Growth Rate in Oligonucleotide Synthesis Business (2018-2023)

Figure 62. Eurogentec Revenue Growth Rate in Oligonucleotide Synthesis Business (2018-2023)

Figure 63. GE Healthcare Revenue Growth Rate in Oligonucleotide Synthesis Business (2018-2023)

Figure 64. LGC Biosearch Technologies Revenue Growth Rate in Oligonucleotide Synthesis Business (2018-2023)

Figure 65. Nitto Denko Avecia Revenue Growth Rate in Oligonucleotide Synthesis Business (2018-2023)

Figure 66. Genscript Revenue Growth Rate in Oligonucleotide Synthesis Business (2018-2023)

Figure 67. Genedesign Revenue Growth Rate in Oligonucleotide Synthesis Business (2018-2023)

Figure 68. TriLink Biotechnologies Revenue Growth Rate in Oligonucleotide Synthesis Business (2018-2023)

Figure 69. Bio-Synthesis Revenue Growth Rate in Oligonucleotide Synthesis Business (2018-2023)

Figure 70. ATDBio Revenue Growth Rate in Oligonucleotide Synthesis Business (2018-2023)

Figure 71. Bottom-up and Top-down Approaches for This Report

Figure 72. Data Triangulation

Figure 73. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Oligonucleotide Synthesis Market Insights, Forecast to 2029

Published Date: August 2023

Report Code: QYRE-Auto-36G13237

Global Oligonucleotide Synthesis Market Insights, Forecast to 2029

FEATURED COMPANIES

Oligonucleotide Synthesis Market Size

Oligonucleotide Synthesis Market

Scope of Oligonucleotide Synthesis Market Report

Chapter Outline

FAQ for this report

How fast is Oligonucleotide Synthesis Market growing?

What is the Oligonucleotide Synthesis Market size in 2029?

Who are the main players in the Oligonucleotide Synthesis Market report?

What are the Type segmentation covered in the Oligonucleotide Synthesis Market report?

What are the End User segmentation covered in the Oligonucleotide Synthesis Market report?

FEATURED COMPANIES

Industrial Services Market

Single User, Electronic (PDF)

Global Diagnostic Imaging Market Research Report 2020

Single User, Electronic (PDF)